Quarterly Result22 May 2026, 03:21 pm
SMS Pharma: FY26 Revenue ₹886.87 Mn, Net Profit ₹2.43 Mn
AI Summary
SMS Pharmaceuticals Ltd's board approved the audited financial results for the year ended March 31, 2026. The company reported revenue from operations of ₹886.87 million and a net profit of ₹2.43 million. The board recommended a final dividend of ₹0.40 per equity share (40%) for FY26, subject to shareholder approval. Additionally, the registered office is being shifted within Hyderabad, and auditors have been appointed/re-appointed for FY27.
Key Highlights
- SMS Pharma's FY26 revenue from operations stood at ₹886.87 million.
- The company reported a net profit of ₹2.43 million for FY26.
- A final dividend of ₹0.40 per share (40%) was recommended for FY26.
- Registered office is being shifted within local limits of Hyderabad, effective May 25, 2026.
- M/s. Annapragada & Co. appointed as Cost Auditors for FY27.
Price Impact
More from SMSPHARMA